Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Allergy Immunotherapy Global Market Report 2025
Request Sample Buy Now
Global Allergy Immunotherapy Market Report 2025

Report Price : $4490.00

Pages : 200

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Allergy Immunotherapy Global Market Report 2025

By Allergy Type (Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy, Other Allergy Types), By Treatment (Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy, Specific Immunotherapy (SIT)), By Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Allergy Immunotherapy Market Overview

• Allergy Immunotherapy market size has reached to $2.88 billion in 2024

• Expected to grow to $5.03 billion in 2029 at a compound annual growth rate (CAGR) of 12.3%

• Growth Driver: Allergy Immunotherapy Market Surges With Growing Prevalence Of Allergic Disorders

• Market Trend: Artificial Intelligence (AI)-Powered Allergy Component Testing For Advanced Allergy Diagnosis

• Europe was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Allergy Immunotherapy Market?

Allergy immunotherapy refers to a type of therapy used to avoid allergic reactions to things like house dust mites, grass pollen, and bee venom. Immunotherapy includes giving the patient increasingly higher dosages of the chemical or allergen they are allergic to.

The main allergy types in allergy immunotherapy are allergic rhinitis, asthma, food allergy, venom allergy, and others. Allergic rhinitis refers to a diagnosis connected to a collection of symptoms that affect the nose. The various treatments involved are immunotherapy (SCIT), sublingual immunotherapy and specific immunotherapy (SIT). The various channels include hospital pharmacy, retail pharmacy and online pharmacy.

Allergy Immunotherapy Global Market Report 2025 Market Size and growth rate 2025 to 2029: Graph

What Is The Allergy Immunotherapy Market Size 2025 And Growth Rate?

The allergy immunotherapy market size has grown rapidly in recent years. It will grow from $2.88 billion in 2024 to $3.16 billion in 2025 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to increasing incidence of allergic diseases, advancements in immunotherapy techniques, growing awareness among patients, government initiatives, improvements in research and development.

What Is The Allergy Immunotherapy Market Growth Forecast?

The allergy immunotherapy market size is expected to see rapid growth in the next few years. It will grow to $5.03 billion in 2029 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to rising global allergy burden, healthcare policy support, increasing acceptance of immunotherapy, emerging markets and untapped regions, increasing healthcare expenditure. Major trends in the forecast period include advancements in treatment technology, increasing allergy prevalence, rise in patient awareness and education, telemedicine and remote monitoring, customized treatment plans.

The forecast of 12.3% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. allergy care by increasing costs for sublingual immunotherapy tablets and allergy shot serums imported from Spain and France, potentially reducing treatment accessibility and raising immunotherapy program expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Allergy Immunotherapy Market Segmented?

1) By Allergy Type: Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy, Other Allergy Types

2) By Treatment: Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy, Specific Immunotherapy (SIT)

3) By Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Allergic Rhinitis: Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis

2) By Asthma: Allergic Asthma, Non-Allergic Asthma

3) By Food Allergy: Peanut Allergy, Tree Nut Allergy, Milk Allergy, Egg Allergy, Other Food Allergies

4) By Venom Allergy: Insect Sting Allergy, Other Venom Allergies

5) By Other Allergy Types: Allergic Conjunctivitis, Eczema, Drug Allergies, Other Environmental Allergies

What Is Driving The Allergy Immunotherapy Market? Allergy Immunotherapy Market Surges With Growing Prevalence Of Allergic Disorders

The rising prevalence of allergic disorders is expected to propel the growth of the allergy immunotherapy market going forward. Allergic disorders refer to excessive immune responses to specific antigens. Immune responses that are inappropriately directed against intrinsic bodily parts (self) result in autoimmune diseases. Allergy immunotherapy is available to atopic people who have allergy disorders like IgE-mediated allergic rhinitis and allergic asthma brought on by inhaled allergens, including pollens and house dust mites (HDMs). For instance, in August 202, according to the Medicines and Healthcare Products Regulatory Agency (MHRA), a UK-based executive agency published that in 2022-23, English hospitals recorded over 25,000 admissions for allergies and anaphylaxis, more than twice the number seen in the last twenty years. Additionally, in May 2024, according to the Food Standards Agency, a UK-based government department published the Patterns and Prevalence of Adult Food Allergy (PAFA) report that around 6% of adults in the UK are affected by food allergies, which is approximately 2.4 million individuals. Therefore, the rising prevalence of allergic disorders is driving the growth of the allergy immunotherapy industry.

What Is Driving The Allergy Immunotherapy Market? Alcohol Consumption Surge Propels Growth In Allergy Immunotherapy Market

The increasing consumption of alcohol is expected to propel the growth of the allergy immunotherapy market going forward. Alcohol refers specifically to ethyl alcohol or ethanol, psychoactive substance and consumption of alcoholic beverages have intoxicating effects which lead to health risks. Alcoholic drinks, such as red wine, contain histamine, which contributes to allergic-like symptoms, are treated using allergy immunotherapy. For instance, in 2024, according to a report published by First Citizens Bank, a US-based financial institution, 2023, direct-to-consumer (DTC) wine case sales saw a 1.2% increase compared to 2022. Further, in December 2023, according to a report published by Kirin Holdings Company Limited, a Japan-based beverage company, about 192.1 million kiloliters of beer were consumed in 2022, up 2.9% from the previous year. Therefore, the increase in alcohol consumption is driving the growth of the allergy immunotherapy industry.

What Is Driving The Allergy Immunotherapy Market? Increasing Healthcare Expenditure Drives The Allergy Immunotherapy Market

The increasing healthcare expenditure is expected to propel the growth of the allergy immunotherapy market going forward. Increased healthcare expenditure often leads to heightened focus on innovative and effective treatment modalities, particularly for prevalent conditions like allergies. Allergy immunotherapy, with its potential to address the root causes of allergic diseases and offer sustained relief, is well-positioned to benefit from this increased financial commitment to healthcare. The expanding financial resources are likely to enhance accessibility to immunotherapy treatments, driving adoption rates and contributing to the overall market expansion. For instance, in May 2023, according to a report published by the Office for National Statistics, a UK-based government department, between 2022 and 2023, healthcare spending in the UK increased by 5.6% compared with growth of 0.9% in 2022. The UK healthcare expenditure in UK healthcare expenditure was around $317.63 billion (£292 billion) in 2023. Therefore, the rise in healthcare expenditures is driving the growth of the systemic aspergillosis and systemic candidiasis market. Therefore, the increased healthcare expenditure will drive the growth of the allergy immunotherapy industry.

Who Are The Major Players In The Global Allergy Immunotherapy Market?

Major companies operating in the allergy immunotherapy market include LETI Pharma, Stallergenes Greer International AG, Allergy Therapeutics plc, ALK-Abelló A/S, HAL Allergy B.V., DBV Technologies, Circassia Pharmaceuticals Inc., Jubilant HollisterStier LLC, Allergopharma GmbH & Co. KG, Biomay AG, Anergis SA, HollisterStier Allergy, Mylan N.V., Adamis Pharmaceuticals Corporation, Desentum Oy, WOLW Pharma Limited, AllerGenics Inc., Greer Laboratories Inc., Aimmune Therapeutics Inc., Reliant Laboratories Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Danaher Corporation, QIAGEN NV, Merck & Co. Inc., Pfizer Inc., Novartis AG, GlaxoSmithKline plc, AstraZeneca plc, Sanofi SA, Teva Pharmaceutical Industries Ltd., Endo Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Cipla Ltd.

What Are The Key Trends Of The Global Allergy Immunotherapy Market? Artificial Intelligence (AI)-Powered Allergy Component Testing For Advanced Allergy Diagnosis

Major companies operating in the allergy immunotherapy market are innovating technological products, such as the artificial intelligence (AI)-powered allergy component testing, to sustain their position in the market. Artificial intelligence (AI)-powered allergy component testing is a novel testing platform based on component resolved diagnostics (CRD) for diagnosing various forms of allergies. For instance, in May 2023, Metropolis Healthcare Limited, an Indian-based Medical laboratory company launched artificial intelligence (AI)-powered allergy component testing. Artificial intelligence (AI)-powered allergy component testing is a fourth-generation allergy testing technology that uses Artificial Intelligence (AI) to assist clinicians in making clinical decisions. It provides great insights, selecting, and optimizing the course of treatment for allergic diseases. It is also capable of predicting the effectiveness of immunotherapy for allergy vaccinations which are effective or not.

Global Allergy Immunotherapy Market Trend: Strategic Partnerships To Expand Capabilities

Major companies operating in the allergy immunotherapy market are adopting a strategic partnership approach to expand their capabilities. Strategic partnerships refer to a process in which companies leverage each other's strengths and resources to achieve mutual benefits and success. In November 2022, Vimian Group AB, a Sweden-based veterinary company, entered into a partnership with Angany Inc., a Canada-based pharmaceutical company dedicated to allergy immunotherapy. With this partnership, Vimian Group AB aims to develop novel vaccines for allergy and atopic dermatitis in companion animals with proprietary eBioparticle-Potentiated Immunotherapy technology.

Need data on a specific region in this market?
Request Customisation

Regional Analysis For The Global Allergy Immunotherapy Market

Europe was the largest region in the allergy immunotherapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the allergy immunotherapy market report during the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Allergy Immunotherapy Market?

The allergy immunotherapy market includes revenues earned by entities by providing monoclonal antibodies and immune checkpoint inhibitors therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Allergy Immunotherapy Industry?

The allergy immunotherapy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the allergy immunotherapy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Allergy Immunotherapy Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $3.16 billion
Revenue Forecast In 2034 $5.03 billion
Growth Rate CAGR of 12.3% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Allergy Type: Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy, Other Allergy Types
2) By Treatment: Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy, Specific Immunotherapy (SIT)
3) By Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy Subsegments: 1) By Allergic Rhinitis: Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis
2) By Asthma: Allergic Asthma, Non-Allergic Asthma
3) By Food Allergy: Peanut Allergy, Tree Nut Allergy, Milk Allergy, Egg Allergy, Other Food Allergies
4) By Venom Allergy: Insect Sting Allergy, Other Venom Allergies
5) By Other Allergy Types: Allergic Conjunctivitis, Eczema, Drug Allergies, Other Environmental Allergies
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled LETI Pharma, Stallergenes Greer International AG, Allergy Therapeutics plc, ALK-Abelló A/S, HAL Allergy B.V., DBV Technologies, Circassia Pharmaceuticals Inc., Jubilant HollisterStier LLC, Allergopharma GmbH & Co. KG, Biomay AG, Anergis SA, HollisterStier Allergy, Mylan N.V., Adamis Pharmaceuticals Corporation, Desentum Oy, WOLW Pharma Limited, AllerGenics Inc., Greer Laboratories Inc., Aimmune Therapeutics Inc., Reliant Laboratories Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Danaher Corporation, QIAGEN NV, Merck & Co. Inc., Pfizer Inc., Novartis AG, GlaxoSmithKline plc, AstraZeneca plc, Sanofi SA, Teva Pharmaceutical Industries Ltd., Endo Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Cipla Ltd.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Allergy Immunotherapy Market Characteristics

3. Allergy Immunotherapy Market Trends And Strategies

4. Allergy Immunotherapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Allergy Immunotherapy Growth Analysis And Strategic Analysis Framework

5.1. Global Allergy Immunotherapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Allergy Immunotherapy Market Growth Rate Analysis

5.4. Global Allergy Immunotherapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Allergy Immunotherapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Allergy Immunotherapy Total Addressable Market (TAM)

6. Allergy Immunotherapy Market Segmentation

6.1. Global Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Allergic Rhinitis

Asthma

Food Allergy

Venom Allergy

Other Allergy Types

6.2. Global Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Subcutaneous Immunotherapy (SCIT)

Sublingual Immunotherapy

Specific Immunotherapy (SIT)

6.3. Global Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

6.4. Global Allergy Immunotherapy Market, Sub-Segmentation Of Allergic Rhinitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Seasonal Allergic Rhinitis

Perennial Allergic Rhinitis

6.5. Global Allergy Immunotherapy Market, Sub-Segmentation Of Asthma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Allergic Asthma

Non-Allergic Asthma

6.6. Global Allergy Immunotherapy Market, Sub-Segmentation Of Food Allergy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Peanut Allergy

Tree Nut Allergy

Milk Allergy

Egg Allergy

Other Food Allergies

6.7. Global Allergy Immunotherapy Market, Sub-Segmentation Of Venom Allergy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Insect Sting Allergy

Other Venom Allergies

6.8. Global Allergy Immunotherapy Market, Sub-Segmentation Of Other Allergy Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Allergic Conjunctivitis

Eczema

Drug Allergies

Other Environmental Allergies

7. Allergy Immunotherapy Market Regional And Country Analysis

7.1. Global Allergy Immunotherapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Allergy Immunotherapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Allergy Immunotherapy Market

8.1. Asia-Pacific Allergy Immunotherapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Allergy Immunotherapy Market

9.1. China Allergy Immunotherapy Market Overview

9.2. China Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Allergy Immunotherapy Market

10.1. India Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Allergy Immunotherapy Market

11.1. Japan Allergy Immunotherapy Market Overview

11.2. Japan Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Allergy Immunotherapy Market

12.1. Australia Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Allergy Immunotherapy Market

13.1. Indonesia Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Allergy Immunotherapy Market

14.1. South Korea Allergy Immunotherapy Market Overview

14.2. South Korea Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Allergy Immunotherapy Market

15.1. Western Europe Allergy Immunotherapy Market Overview

15.2. Western Europe Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Allergy Immunotherapy Market

16.1. UK Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Allergy Immunotherapy Market

17.1. Germany Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Allergy Immunotherapy Market

18.1. France Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Allergy Immunotherapy Market

19.1. Italy Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Allergy Immunotherapy Market

20.1. Spain Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Allergy Immunotherapy Market

21.1. Eastern Europe Allergy Immunotherapy Market Overview

21.2. Eastern Europe Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Allergy Immunotherapy Market

22.1. Russia Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Allergy Immunotherapy Market

23.1. North America Allergy Immunotherapy Market Overview

23.2. North America Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Allergy Immunotherapy Market

24.1. USA Allergy Immunotherapy Market Overview

24.2. USA Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Allergy Immunotherapy Market

25.1. Canada Allergy Immunotherapy Market Overview

25.2. Canada Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Allergy Immunotherapy Market

26.1. South America Allergy Immunotherapy Market Overview

26.2. South America Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Allergy Immunotherapy Market

27.1. Brazil Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Allergy Immunotherapy Market

28.1. Middle East Allergy Immunotherapy Market Overview

28.2. Middle East Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Allergy Immunotherapy Market

29.1. Africa Allergy Immunotherapy Market Overview

29.2. Africa Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Allergy Immunotherapy Market Competitive Landscape And Company Profiles

30.1. Allergy Immunotherapy Market Competitive Landscape

30.2. Allergy Immunotherapy Market Company Profiles

30.2.1. LETI Pharma Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Stallergenes Greer International AG Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Allergy Therapeutics plc Overview, Products and Services, Strategy and Financial Analysis

30.2.4. ALK-Abelló A/S Overview, Products and Services, Strategy and Financial Analysis

30.2.5. HAL Allergy B.V. Overview, Products and Services, Strategy and Financial Analysis

31. Allergy Immunotherapy Market Other Major And Innovative Companies

31.1. DBV Technologies

31.2. Circassia Pharmaceuticals Inc.

31.3. Jubilant HollisterStier LLC

31.4. Allergopharma GmbH & Co. KG

31.5. Biomay AG

31.6. Anergis SA

31.7. HollisterStier Allergy

31.8. Mylan N.V.

31.9. Adamis Pharmaceuticals Corporation

31.10. Desentum Oy

31.11. WOLW Pharma Limited

31.12. AllerGenics Inc.

31.13. Greer Laboratories Inc.

31.14. Aimmune Therapeutics Inc.

31.15. Reliant Laboratories Inc.

32. Global Allergy Immunotherapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Allergy Immunotherapy Market

34. Recent Developments In The Allergy Immunotherapy Market

35. Allergy Immunotherapy Market High Potential Countries, Segments and Strategies

35.1 Allergy Immunotherapy Market In 2029 - Countries Offering Most New Opportunities

35.2 Allergy Immunotherapy Market In 2029 - Segments Offering Most New Opportunities

35.3 Allergy Immunotherapy Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Allergy Immunotherapy Market, Sub-Segmentation Of Allergic Rhinitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Allergy Immunotherapy Market, Sub-Segmentation Of Asthma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Allergy Immunotherapy Market, Sub-Segmentation Of Food Allergy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Allergy Immunotherapy Market, Sub-Segmentation Of Venom Allergy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Allergy Immunotherapy Market, Sub-Segmentation Of Other Allergy Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Allergy Immunotherapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Allergy Immunotherapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: LETI Pharma Financial Performance
  • Table 80: Stallergenes Greer International AG Financial Performance
  • Table 81: Allergy Therapeutics plc Financial Performance
  • Table 82: ALK-Abelló A/S Financial Performance
  • Table 83: HAL Allergy B.V. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Allergy Immunotherapy Market, Sub-Segmentation Of Allergic Rhinitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Allergy Immunotherapy Market, Sub-Segmentation Of Asthma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Allergy Immunotherapy Market, Sub-Segmentation Of Food Allergy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Allergy Immunotherapy Market, Sub-Segmentation Of Venom Allergy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Allergy Immunotherapy Market, Sub-Segmentation Of Other Allergy Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Allergy Immunotherapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Allergy Immunotherapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: LETI Pharma Financial Performance
  • Figure 80: Stallergenes Greer International AG Financial Performance
  • Figure 81: Allergy Therapeutics plc Financial Performance
  • Figure 82: ALK-Abelló A/S Financial Performance
  • Figure 83: HAL Allergy B.V. Financial Performance

Next-Gen Primary Health Care Service : Market Forecast, Transformation, and Long-Term Trajectories

Read More About Next-Gen Primary Health Care Service : Market Forecast, Transformation, and Long-Term Trajectories

Progressive Ataxia And Weakness Disorders Growth Trajectory: Key Forecasts and Strategic Insights

Read More About Progressive Ataxia And Weakness Disorders Growth Trajectory: Key Forecasts and Strategic Insights

Prostate Cancer Nuclear Medicine Diagnostics Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Read More About Prostate Cancer Nuclear Medicine Diagnostics Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Emerging Trends Redefining the Prostate Cancer Nuclear Medicine Diagnostics Market Landscape: Automated Parallel Capillary Electrophoresis Systems Transforming Protein Analysis In The Protein Chip Market

Read More About Emerging Trends Redefining the Prostate Cancer Nuclear Medicine Diagnostics Market Landscape: Automated Parallel Capillary Electrophoresis Systems Transforming Protein Analysis In The Protein Chip Market

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Explore future trends in the global pharma and biotech CRM software market. Understand market growth, drivers, and industry outlook through 2034.

Read More About Explore future trends in the global pharma and biotech CRM software market. Understand market growth, drivers, and industry outlook through 2034.

Explore market drivers and forecast in the nasal spray influenza vaccine sector through 2025–2034.

Read More About Explore market drivers and forecast in the nasal spray influenza vaccine sector through 2025–2034.

Review key data-driven trends shaping the global data storage market in 2025.

Read More About Review key data-driven trends shaping the global data storage market in 2025.

Oil And Gas Cloud Applications Global Market Report 2025 – By Component( Solutions, Services), By Operation( Upstream, Midstream, Downstream), By Deployment Model( Hybrid, Private, Public ) – Impact of Tariff and Trade W...

View Report

Brine Concentration Technology (BCT) Global Market Report 2025 – By Technology (High Energy Reverse Osmosis, Mechanical Vapor Compression, Closed Circuit Desalination, Vertical Tube Falling Film, Other Technologies), By ...

View Report

Allergy Diagnostics Global Market Report 2025 – By Test Type (In-vivo Allergy Tests, In-vitro Allergy Tests ), By Allergen (Inhaled Allergens, Food Allergens, Drug Allergens ), By Products (Consumables, Instruments, Lumi...

View Report

Cellular Immunotherapy Global Market Report 2025 – By Therapy (Tumor-Infiltrating Lymphocyte (TIL) Therapy, Engineered T Cell Receptor (TCR) Therapy, Chimeric Antigen Receptor (CAR) T Cell Therapy, Natural Killer (NK) Ce...

View Report

Nasal Spray Bottle Global Market Report 2025 – By Product Type (Saline Nasal Spray, Decongestion Nasal Spray, Steroid Nasal Spray, Antihistamine Nasal Spray), By Container Design (Pump Bottles, Pressurized Canisters), By...

View Report

Veterinary Infectious Disease Diagnostics Global Market Report 2025 – By Infection Type (Viral Infections, Bacterial Infections, Parasitic Infections, Other Infections), By Animal Type (Companion Animal, Food-Producing a...

View Report

Dendritic Cell Cancer Vaccine Global Market Report 2025 – By Product (CreaVax, Sipuleucel-T (Provenge), Other Products), By Distribution Channel (Hospitals, Cancer Centers, Ambulatory Surgical Centers, Clinics), By Appli...

View Report

Bed Head Panel Global Market Report 2025 – By Type (Vertical Bed Head Panels, Horizontal Bed Head Panels), By Specialty (Intensive Care Unit (ICU), Surgical, Other Specialties), By End Use (Hospitals, Clinics, Other End-...

View Report

Frequently Asked Questions

Allergy immunotherapy refers to a type of therapy used to avoid allergic reactions to things like house dust mites, grass pollen, and bee venom. Immunotherapy includes giving the patient increasingly higher dosages of the chemical or allergen they are allergic to. For further insights on this market, request a sample here

The market major growth driver - Allergy Immunotherapy Market Surges With Growing Prevalence Of Allergic Disorders. For further insights on this market, request a sample here

The allergy immunotherapy market size has grown strongly in recent years. It will grow from $2.88 billion in 2024 to $3.16 billion in 2025 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to increasing incidence of allergic diseases, advancements in immunotherapy techniques, growing awareness among patients, government initiatives, improvements in research and development. The allergy immunotherapy market size is expected to see rapid growth in the next few years. It will grow to " $5.03 billion in 2029 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to rising global allergy burden, healthcare policy support, increasing acceptance of immunotherapy, emerging markets and untapped regions, increasing healthcare expenditure. Major trends in the forecast period include advancements in treatment technology, increasing allergy prevalence, rise in patient awareness and education, telemedicine and remote monitoring, customized treatment plans. For further insights on this market, request a sample here

The allergy immunotherapymarket covered in this report is segmented –
1) By Allergy Type: Allergic Rhinitis; Asthma; Food Allergy; Venom Allergy; Other Allergy Types
2) By Treatment: Subcutaneous Immunotherapy (SCIT); Sublingual Immunotherapy; Specific Immunotherapy (SIT)
3) By Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy Subsegments:
1) By Allergic Rhinitis: Seasonal Allergic Rhinitis; Perennial Allergic Rhinitis
2) By Asthma: Allergic Asthma; Non-Allergic Asthma
3) By Food Allergy: Peanut Allergy; Tree Nut Allergy; Milk Allergy; Egg Allergy; Other Food Allergies
4) By Venom Allergy: Insect Sting Allergy; Other Venom Allergies
5) By Other Allergy Types: Allergic Conjunctivitis; Eczema; Drug Allergies; Other Environmental Allergies For further insights on this market, request a sample here

Europe was the largest region in the allergy immunotherapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the allergy immunotherapy market report during the forecast period. The regions covered in the allergy immunotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on this market, request a sample here.

Major companies operating in the allergy immunotherapy market include LETI Pharma, Stallergenes Greer International AG, Allergy Therapeutics plc, ALK-Abelló A/S, HAL Allergy B.V., DBV Technologies, Circassia Pharmaceuticals Inc., Jubilant HollisterStier LLC, Allergopharma GmbH & Co. KG, Biomay AG, Anergis SA, HollisterStier Allergy, Mylan N.V., Adamis Pharmaceuticals Corporation, Desentum Oy, WOLW Pharma Limited, AllerGenics Inc., Greer Laboratories Inc., Aimmune Therapeutics Inc., Reliant Laboratories Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Danaher Corporation, QIAGEN NV, Merck & Co. Inc., Pfizer Inc., Novartis AG, GlaxoSmithKline plc, AstraZeneca plc, Sanofi SA, Teva Pharmaceutical Industries Ltd., Endo Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Cipla Ltd. . For further insights on this market, request a sample here.

Major trends in this market include Artificial Intelligence (AI)-Powered Allergy Component Testing For Advanced Allergy Diagnosis. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Allergy Immunotherapy Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon